Category: Life Sciences
Global Life Sciences
-
Hematology Instruments and Reagents
... 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Hematology Analyzers, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$4.3 Billion by the ... Read More
-
Cardiac Rhythm Management (CRM) Devices
... Billion by 2030, growing at a CAGR of 3.7% over the analysis period 2024-2030. Defibrillators, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$11.3 Billion by ... Read More
-
Chiropractic Care
... CAGR of 3.6% over the analysis period 2024-2030. Relief Care, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$25.6 Billion by the end of the analysis ... Read More
-
Clinical Trial Management Systems (CTMS)
... Billion by 2030, growing at a CAGR of 14.6% over the analysis period 2024-2030. Enterprise-Wide CTMS, one of the segments analyzed in the report, is expected to record a 15.1% CAGR and reach US$3.1 Billion ... Read More
-
H1N1 Vaccines
... CAGR of 5.4% over the analysis period 2024-2030. Intramuscular Vaccines, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$1.1 Billion by the end of the analysis ... Read More
-
Lymphoma Therapeutics
... CAGR of 6.5% over the analysis period 2024-2030. Non-Hodgkin Lymphoma (NHL) Therapeutics, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$20.5 Billion by the end of ... Read More
-
Clinical Nutrition Products
... at a CAGR of 4.0% over the analysis period 2024-2030. Oral Nutrition, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$28.7 Billion by the end of ... Read More
-
Hormone Replacement Therapy (HRT)
... 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Estrogen Hormone Replacement Therapy, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$24.2 Billion ... Read More
-
High Content Screening (HCS)
... 2030, growing at a CAGR of 9.2% over the analysis period 2024-2030. HCS Instruments, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$1.0 Billion by the ... Read More
-
Heart Healthy Ingredients
... at a CAGR of 4.2% over the analysis period 2024-2030. Omega-3 Ingredient, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$12.4 Billion by the end of ... Read More
-
Dental Implants
... CAGR of 6.1% over the analysis period 2024-2030. Titanium Material, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$10.2 Billion by the end of the analysis ... Read More
-
mHealth (Mobile Health) Services
... 2030, growing at a CAGR of 27.9% over the analysis period 2024-2030. Monitoring Services, one of the segments analyzed in the report, is expected to record a 27.0% CAGR and reach US$139.8 Billion by the ... Read More
-
Glucosamine
... 6.9% over the analysis period 2024-2030. Nutritional Supplements Application, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$1.2 Billion by the end of the analysis period. ... Read More
-
Biomarkers
... 13.7% over the analysis period 2024-2030. Safety Biomarkers, one of the segments analyzed in the report, is expected to record a 13.9% CAGR and reach US$89.8 Billion by the end of the analysis period. Growth ... Read More
-
Intracranial Stents
... CAGR of 12.9% over the analysis period 2024-2030. Self-Expanding Stents, one of the segments analyzed in the report, is expected to record a 13.9% CAGR and reach US$594.0 Million by the end of the analysis ... Read More
-
Advanced (3D/4D) Visualization Systems
... 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. MRI Modality, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$1.7 Billion by the ... Read More
-
Circulating Tumor Cell (CTC) Diagnostics
... Billion by 2030, growing at a CAGR of 11.1% over the analysis period 2024-2030. Detection & Enrichment Technology, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach ... Read More
-
Brain Monitoring Devices
... at a CAGR of 3.7% over the analysis period 2024-2030. Brain Monitoring Devices, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$5.8 Billion by the end ... Read More
-
Dental Preventive Supplies
... at a CAGR of 4.3% over the analysis period 2024-2030. The U.S. Market is Estimated at US$156.3 Million While China is Forecast to Grow at 6.4% CAGR The Dental Preventive Supplies market in the U.S. ... Read More
-
Pediatric Drugs and Vaccines
... 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Conjugate Technology, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$52.0 Billion by the ... Read More
-
Protein Sequencing
... CAGR of 2.9% over the analysis period 2024-2030. Mass Spectrometry Technology, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$973.5 Million by the end of the ... Read More
-
Rabies Diagnostics
... CAGR of 5.4% over the analysis period 2024-2030. Fluorescent Antibody Tests (FAT) Method, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$910.1 Million by the end ... Read More
-
Veterinary Electrosurgery
... CAGR of 8.6% over the analysis period 2024-2030. Bipolar Electrosurgery Instruments, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$74.4 Million by the end of the ... Read More
-
Wearable Fitness Technology
... at a CAGR of 13.3% over the analysis period 2024-2030. Smartwatches, one of the segments analyzed in the report, is expected to record a 15.0% CAGR and reach US$11.0 Billion by the end of the ... Read More
-
Sleep Apnea Diagnostic and Therapeutic Devices
... reach US$14.0 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. Diagnostic Devices, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach ... Read More
Research Assistance
